Director, Epidemiology & RWE Sciences

Ipsen Biopharmaceuticals Inc.; United States; On-site; USD 180,000 - 260,000; Full time

Job summary

Ipsen Biopharmaceuticals Inc. seeks a Director of Epidemiology & RWE Sciences to lead global evidence programs across oncology assets.

This role directs the evidence strategy, oversees real-world studies, registries, and data analyses to inform regulatory, payer, and clinical decisions. Collaboration with Medical Affairs, Regulatory, and HEOR will be essential to ensure timely, fit-for-purpose evidence generation.

Responsibilities

• Evidence Strategy

Job description

Director, Epidemiology & RWE Sciences - Ipsen Biopharmaceuticals Inc.

About Ipsen: Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation. Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society! For more information, visit us at https://www.ipsen.com/ and follow our latest news on LinkedIn and Instagram.

Job Description

The Director, Epidemiology and RWE Sciences will support pre- and post-launch evidence generating activities across all Oncology products. The role is responsible for leading the global evidence strategy and real‑world evidence generation for Ipsen’s oncology assets across the product lifecycle. This role provides scientific and strategic leadership to ensure that robust, fit‑for‑purpose RWE is generated to support regulatory, payer, clinical, and medical decision‑making, with a strong focus on high‑unmet‑need oncology indications. The Director will define and execute integrated evidence plans (IEPs), oversee RWE studies (e.g., registries, retrospective and prospective observational studies, database studies), and partner closely with Global Medical Affairs, Clinical Development, Regulatory Affairs, Market Access, HEOR, Biostatistics, and Safety. The role will be responsible for methodological epidemiological & RWE leadership and will contribute the development of new SOPs and guidance documents that will promote and ensure timely and high-quality, “fit‑for‑purpose” evidence generation. The Director will also take a lead in serving as a subject matter expert and in building capacity for RWE research across the business. The role operates in a global, matrixed environment and ensures evidence generation adheres to scientific, regulatory, and compliance standards.

WHAT - Main Responsibilities & Technical Competencies

• Evidence Strategy